Journal profile · Medicine, General & Internal
Revista de Investigacion Clinica-Clinical and Translational Investigation
ISSN 0034-8376 · eISSN 2385-3956 · Instituto Nacional de la Nutricion Salvador Zubiran · MEXICO · Bimonthly · Founded 1948
Revista de Investigacion Clinica-Clinical and Translational Investigation: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.98; diamond open access (no APC); no APC; median 55 days to acceptance (42 articles, last 24 months); community-reported acceptance: easy; 27 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Revista de Investigacion Clinica-Clinical and Translational Investigation is published by Instituto Nacional de la Nutricion Salvador Zubiran and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, Health and Medical Education and Renal Transplantation Outcomes and Treatments, together about 20.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Revista de Investigación Clínica - Clinical and Translational Investigation publishes original clinical and biomedical research of interest to physicians in internal medicine, surgery, and any of their specialties.
From the journal's Aims & Scope
Research area (LetPub): Medicine, General & Internal
Editor-in-chief Alfredo Ulloa-AguirrePublisher website
Editorial board by country: none in mainland China; most named Mexico 74, United States 18, Canada 2, Spain 1, Argentina 1 (96 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine7.2%
- Health and Medical EducationHealth Professions7%
- Renal Transplantation Outcomes and TreatmentsMedicine6.2%
- Health and Lifestyle StudiesHealth Professions6.2%
- Ethics and bioethics in healthcareMedicine5.4%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine4.4%
- Dialysis and Renal Disease ManagementMedicine4.1%
- Acute Lymphoblastic Leukemia researchMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPublisher website
Other: EBSCO, Latindex, Clarivate’s Journal Citation ReportsTM 2023, SCRM Conacyt, Latindex (Catalogue and Directory), Artemisa, Imbiomed, EBSCO EssentialsTM, MIAR
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.98LetPub ·
- Impact factor (publisher)
- 1.5Publisher website ·
- CiteScore 2026-06
- 3.3LetPub ·
- SJR 2026-06
- 0.49LetPub ·
- SNIP 2026-06
- 0.27LetPub ·
- h-index
- 25LetPub ·
- h-index
- 30OpenAlex ·
- i10-index
- 167OpenAlex ·
- 2-year mean citedness
- 0.86OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 76.64%LetPub ·
Volume
- Articles per year
- 49LetPub ·
Articles by year OpenAlex count · 918 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 26 | 26 | 2 |
| 2025 | 27 | 27 | 16 |
| 2024 | 31 | 31 | 54 |
| 2023 | 37 | 37 | 194 |
| 2022 | 35 | 35 | 223 |
| 2021 | 46 | 46 | 248 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
55 daysMedian, submission to acceptance · P25–P75 38 days – 95 days
- Acceptance to online
- median 23 days (42 articles)
- Submission to online
- median 88 days
- Sample
- 42 articles with submission and acceptance dates (57 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| OpenAlex | USD 2,000 / EUR 1,870 / GBP 1,600 / JPY 248,060 | — | — |
Other charges and waivers (author guidelines)
- Colour charges
- No colour charges
- Other fees
- No other fees
- Page charges
- No page charges
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 200 words
- Manuscript length
- ≤ 4,000 words
Article types accepted10, with length limits
- brief communicationat may have a major impact in medicine. Brief Communications are limited to 4,000 words, including the abstract, introduction, materials and methodmain text ≤ 4,000 words
- brief communicationsTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
- brief reviewsTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
- commentariesTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
- in-depth reviewIn-Depth Review : Shaofei Zhao, Qian Yang, Changjun GaoLength not stated
- in-depth reviewsTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
- letters to the editorTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
- original articlesTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
- perspectivesTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
- research lettersTypes of manuscripts: – Brief Communications – Commentaries – Research Letters – Original Articles – Brief Reviews – In-depth Reviews – Perspectives – Letters t…Length not stated
Policy excerpts from the journal's websiteOpen access
- Open access
Open access, immediate and permanent free access for everyone to read and download. Model summary
All articles published are open access and can be immediately and permanently free for everyone to read and download.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Instituto Nacional de la Nutricion Salvador Zubiran
- Country or region
- MEXICO
- Language
- Multi-Language
- Frequency
- Bimonthly
- Founded
- 1948
- ISSN
- 0034-8376
- Electronic ISSN
- 2385-3956
- Society / sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about Revista de Investigacion Clinica-Clinical and Translational Investigation
What CAS zone is Revista de Investigacion Clinica-Clinical and Translational Investigation in?
In the 2025 upgraded edition of the CAS Journal Ranking, Revista de Investigacion Clinica-Clinical and Translational Investigation is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Revista de Investigacion Clinica-Clinical and Translational Investigation?
The latest impact factor listed by LetPub is 1.98; CiteScore 3.3, h-index 30.
How long does peer review take at Revista de Investigacion Clinica-Clinical and Translational Investigation?
Based on the dates recorded on 42 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 55 days (interquartile range 38–95 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Revista de Investigacion Clinica-Clinical and Translational Investigation?
According to the journal's author guidelines: Abstract: ≤ 200 words; Manuscript length: ≤ 4,000 words. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Revista de Investigacion Clinica-Clinical and Translational Investigation based?
Of the 96 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Mexico (74), United States (18) and Canada (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Revista de Investigacion Clinica-Clinical and Translational Investigation?
According to LetPub and DOAJ records, Revista de Investigacion Clinica-Clinical and Translational Investigation is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE; that list has not been checked against each database.
Is Revista de Investigacion Clinica-Clinical and Translational Investigation open access, and what is the APC?
Revista de Investigacion Clinica-Clinical and Translational Investigation is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .